FITLIFE BRANDS, INC. Accretion Expense
FITLIFE BRANDS, INC. (FTLF) reported Accretion Expense of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2020-03-30
- FITLIFE BRANDS, INC. accretion expense for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- FITLIFE BRANDS, INC. accretion expense for fiscal 2018 was $105.00K.
- FITLIFE BRANDS, INC. accretion expense for fiscal 2017 was $0.00.
| Period end | Accretion Expense 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-30 |
| 2018-12-31 | $105.00K 10-K · filed 2020-03-30 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |